Discharge education video to reduce post-operative healthcare use after HoLEP
The Impact of Discharge Educational Discharge Videos on Post-Operative Care Utilization After Holmium Laser Enucleation of the Prostate (HoLEP) Procedures
This will test whether showing an educational discharge video to adults undergoing HoLEP reduces post-operative healthcare visits and improves patient satisfaction.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 114 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 3 sites (San Francisco, California and 2 other locations) |
| Trial ID | NCT06975033 on ClinicalTrials.gov |
What this trial studies
This randomized interventional study will enroll adults scheduled for Holmium Laser Enucleation of the Prostate (HoLEP) at three U.S. academic centers. After the procedure, participants will be randomized to watch a scripted educational discharge video or to receive standard discharge care without the video. Investigators will monitor post-operative healthcare utilization such as phone calls, emergency visits, and readmissions and will collect baseline and follow-up surveys. Secondary outcomes include patient satisfaction with discharge education.
Who should consider this trial
Good fit: Adults aged 18 or older scheduled for HoLEP who speak English, can provide informed consent, and are willing to complete baseline and follow-up surveys are ideal candidates.
Not a fit: Patients who are non-English speakers, unable to consent or complete surveys, or who do not have a prostate are not eligible and would not be expected to benefit.
Why it matters
Potential benefit: If successful, the video could lower unnecessary post-discharge calls and visits, increase patient confidence in self-care, and reduce healthcare costs.
How similar studies have performed: Educational discharge materials and videos have reduced post-operative calls and readmissions in other surgical populations, but this approach has been less studied specifically after HoLEP.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults aged 18+ 2. Patients scheduled for a HoLEP procedure 3. Patients willing to complete both baseline and follow up surveys 4. Patients able to provide informed consent 5. Patients are English-speaking and understand English Exclusion Criteria: 1. Patients under 18+ 2. Patients unable to consent 3. Patients unable to complete surveys 4. Patients without a prostate. 5. Patients are non-English speakers
Where this trial is running
San Francisco, California and 2 other locations
- University of California, San Francisco — San Francisco, California, United States (Recruiting)
- University of Rochester Medical Center — Rochester, New York, United States (Not_yet_recruiting)
- Scott SUNY Upstate Medical University — Syracuse, New York, United States (Not_yet_recruiting)
Study contacts
- Principal investigator: David Bayne, MD, MPH — University of California, San Francisco
- Study coordinator: David Bayne, MD, MPH
- Email: david.bayne@ucsf.edu
- Phone: 617-571-5870
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.